BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2964931)

  • 21. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
    Youngner JS; Salvin SB
    J Immunol; 1973 Dec; 111(6):1914-22. PubMed ID: 4356326
    [No Abstract]   [Full Text] [Related]  

  • 22. Production and partial characterization of dog macrophage migration inhibitory factor.
    Schnizlein CT; Bice DE
    J Reticuloendothel Soc; 1980 Apr; 27(4):393-400. PubMed ID: 6989994
    [No Abstract]   [Full Text] [Related]  

  • 23. [Macrophage inhibitory factor in pregnant women (author's transl)].
    Knobloch V; Jouja V; Svobodová M
    Cesk Gynekol; 1978 Mar; 43(1):11-4. PubMed ID: 346241
    [No Abstract]   [Full Text] [Related]  

  • 24. Delayed hypersensitivity pleurisy in guinea pigs; demonstration of reduced migration ability of macrophages in vitro.
    Yamamoto S; Ishikura A; Higuchi Y
    J Pathol; 1980 Jun; 131(2):137-44. PubMed ID: 7000987
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).
    Mitchell RA; Bucala R
    Semin Cancer Biol; 2000 Oct; 10(5):359-66. PubMed ID: 11100884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
    Pick E
    Immunology; 1974 Mar; 26(3):649-58. PubMed ID: 4369184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of migration inhibitory factor on macrophage subpopulations.
    Ziemba LJ; Saha A
    Indian J Exp Biol; 1980 Feb; 18(2):106-11. PubMed ID: 6995281
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biological aspects of the macrophage migration inhibition factor (MIF)].
    Cavallo GP; Landolfo S
    G Batteriol Virol Immunol; 1980; 73(7-12):196-201. PubMed ID: 7030846
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: The use of the cell migration inhibition test.
    Spitler LE
    J Immunol; 1974 Jan; 112(1):436. PubMed ID: 4590827
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interaction between cellular and serum factors of immunity in the dynamics of chemical carcinogenesis].
    Maĭskiĭ IN; Aĭrapet'ian GP; Gudkova RB; Krylova LD
    Biull Eksp Biol Med; 1974 Nov; 78(11):86-9. PubMed ID: 4614879
    [No Abstract]   [Full Text] [Related]  

  • 32. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice.
    Korsgren M; Källström L; Uller L; Bjerke T; Sundler F; Persson CG; Korsgren O
    Mediators Inflamm; 2000; 9(1):15-23. PubMed ID: 10877450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Migration inhibition test in experimental and clinical studies].
    Libiszowski T
    Wiad Lek; 1974 Nov; 27(22):1959-63. PubMed ID: 4613009
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nature of the cells regulating the production of a migration inhibition factor in C57BL/6 strain mice with low response to Candida albicans antigen].
    Vorob'ev KV; Koval'chuk LV; Gankovskaia LV
    Biull Eksp Biol Med; 1984 Nov; 98(11):601-2. PubMed ID: 6239664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
    Schober A; Bernhagen J; Thiele M; Zeiffer U; Knarren S; Roller M; Bucala R; Weber C
    Circulation; 2004 Jan; 109(3):380-5. PubMed ID: 14691040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis.
    Honda A; Abe R; Yoshihisa Y; Makino T; Matsunaga K; Nishihira J; Shimizu H; Shimizu T
    Carcinogenesis; 2009 Sep; 30(9):1597-605. PubMed ID: 19584138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition test of macrophage migration in the study of various dermatoses].
    Castells Rodellas A; Castel Rodo T
    Actas Dermosifiliogr; 1973; 64(7-8):323-34. PubMed ID: 4611152
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of tilorone-induced mouse migration inhibitory factor by affinity chromatography and isoelectric focusing.
    Fahlbusch B; Zschiesche W; Römer W
    Acta Biol Med Ger; 1981; 40(2):147-52. PubMed ID: 7023160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
    Akiyoshi T; Hata A; Tsuji H
    Gan; 1975 Apr; 66(2):167-74. PubMed ID: 1097286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.